Cargando…
Glioblastoma patient-derived cell-based phenotypic drug screening and identification of possible action mechanisms through proteomic analysis
Because glioblastoma (GBM) exhibits high heterogeneity, it is desirable to use patient-derived cells from the first stage of screening for GBM drug discovery. Here, we describe a protocol to culture patient-derived GBM cells on the extracellular matrix-coated plates to allow high-throughput screenin...
Autores principales: | Kim, Young Eun, Kim, Hyun Young, Jung, Daeyoung, Kang, Dukjin, Nam, Do-Hyun, Nam, Hye Jin, Cho, Heeyeong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8476855/ https://www.ncbi.nlm.nih.gov/pubmed/34611628 http://dx.doi.org/10.1016/j.xpro.2021.100849 |
Ejemplares similares
-
Azathioprine antagonizes aberrantly elevated lipid metabolism and induces apoptosis in glioblastoma
por: Nam, Hye Jin, et al.
Publicado: (2021) -
MeCP2 dysfunction prevents proper BMP signaling and neural progenitor expansion in brain organoid
por: Hong, Hyowon, et al.
Publicado: (2023) -
NTRK1 Fusion in Glioblastoma Multiforme
por: Kim, Jinkuk, et al.
Publicado: (2014) -
SILAC-Based Quantitative Proteomic Analysis of Oxaliplatin-Resistant Pancreatic Cancer Cells
por: Kim, Young Eun, et al.
Publicado: (2021) -
Proteomic analysis predicts anti-angiogenic resistance in recurred glioblastoma
por: Jeon, Hanwool, et al.
Publicado: (2023)